Across four parts of the “FDA Watch” podcast series featuring Skadden partners and counsel, legal and industry panelists convened between March ...
The One Big Beautiful Bill Act (OBBBA), when signed into law on July 4, 2025, imposed a number of new restrictions and requirements on energy ...
Drug developers face new regulatory uncertainty because the status of a number of ambitious changes to FDA’s review processes are in doubt following the departure of Commissioner Marty Makary and many ...
In one of the most significant class action rulings in website tracking litigation to date, a California federal court just ...
The latest Weekly Sweep highlights significant developments from across the Northeast involving debt collection enforcement, auto finance ...
Antitrust authorities in the United States, Europe and Asia have shown increased openness to merger remedies, including behavioral ones.
Bank regulators have signaled a renewed openness to de novo bank charter applications, creating new opportunities for fintech ...
Spinal cord injuries from traumatic accidents can have devastating consequences. They can lead to chronic pain and permanent ...
Each year the New Jersey Bureau of Securities (the “Bureau”) publishes an examination that all New Jersey registered ...
In this episode, Gabe Scott, Kevin Alonso, and Cindy Laura Ortega Ramos unpack recent updates to the federal independent dispute resolution ...
This briefing note looks in detail at the proposed amendments to the Trusts (Guernsey) Law, 2007. These proposals are ...
On June 18, 2026, the Federal Energy Regulatory Commission (“FERC” or the “Commission”) announced two orders at its June 2026 Open Meeting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results